Research in Motion with ioSkeletal Myocytes

Dr Will Bernard, Senior Scientist at bit.bio, and Dr Luke Flatt, Senior Scientist at Charles River discuss how bit.bio’s iPSC-derived ioSkeletal Myocytes can facilitate HTS workflows and accelerate research into muscle and metabolic disease.

Introducing human iPSC-derived muscle cells for research and drug discovery.

This webinar showcases:

• How highly-defined and characterised muscle cells can provide physiological relevance earlier in your research and drug development pipeline.
• The potential of ioSkeletal Myocytes as a relevant translational model for research of muscle, neuromuscular and associated metabolic disorders.
• How human induced skeletal myocytes have been generated by opti-ox™ cellular reprogramming to offer consistency at scale, easy culture and rapid maturity.